Navigation Links
Delaying Health Care Reform is U-N-A-C-C-E-P-T-A-B-L-E!
Date:7/27/2009

uth Capitol Street, S.E. Washington, DC 20003, 11:30AM-1:30PM.

A press conference will be held at the site of each rally at 12:45PM. The campaign is also planning to hold future rallies should Congress go into their recess without a meaningful agreement on healthcare reform.

For more information or to schedule an interview with Rev. Delman L. Coates regarding this campaign, call (301) 238-4979, visit www.enoughisenoughhealth.com (under construction) website, or send an email to: enoughisenoughcampaign@hotmail.com.


'/>"/>
SOURCE Enough Is Enough Campaign for Health Care Reform
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Risks of Delaying ACL Reconstruction in Young Athletes May Be Too High, Study Shows
2. Avastin effective at delaying brain tumor progression in recurrent disease
3. Safety of Labor-Delaying Drugs Questioned
4. Combination of TYKERB(R) (lapatinib) Plus Letrozole Demonstrated Significant Improvement in Delaying Disease Progression for HER2+/ErbB2+ Post-Menopausal Metastatic Breast Cancer
5. Study: Delaying evolution of drug resistance in malaria parasite possible
6. Delaying school start time by one hour positively affects adolescents cognitive performance
7. Excessive overtriage in US trauma centers overwhelming system resources, delaying patient care
8. Premier Visiting Nurse Selects Cardiocom Telehealth Technology
9. Leading health organizations launch new accreditation process for laboratories across Africa
10. Landrieu Comments on Presidents Small Business Health Care Report
11. North Memorial Health Care and Blue Cross and Blue Shield of Minnesota Reach Contract Agreement for Clinics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... -- Allscripts (Nasdaq: MDRX ) announced today ... the three and six months ended November 30, ... January 11, 2010. Allscripts management will host a ... earnings and other information at 8:30 AM Eastern ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter ...
(Date:12/16/2009)... Mich., Dec. 16 The most widely used human ... that raises social justice questions that must be addressed ... stem cell advances, according to a University of Michigan ... its kind, the U-M team analyzed 47 embryonic stem ... by stem cell researchers. The scientists determined the genetic ...
(Date:12/16/2009)... Institute will sponsor a new learning collaborative ... who serve individuals at risk of, or ... plan, medical home and other provider settings. ... webinars on topics, solutions and case studies ... improvement. Each webinar will include a brief ...
(Date:12/16/2009)... susceptibility to disease , , WEDNESDAY, Dec. 16 (HealthDay ... to leprosy have been identified by scientists in ... more than 10,000 DNA samples from leprosy patients ... highlights the important role that the innate immune ... "Though leprosy is not common, the discoveries have ...
(Date:12/16/2009)... Wellcome Trust Sanger Institute announce the first comprehensive analyses ... by mutations in the DNA of cancer cells which ... a malignant melanoma and a lung cancer, reveal for ... genomes of two cancers. , Lung cancer causes around ... associated with smoking. The number of mutations found suggest ...
Breaking Medicine News(10 mins):Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 2Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 3Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 4Health News:U-M Study Reveals Surprising Lack of Genetic Diversity in the Most Widely Used Human Embryonic Stem Cell Lines 5Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Leprosy Genes Identified 2Health News:Lung cancer and melanoma laid bare 2Health News:Lung cancer and melanoma laid bare 3Health News:Lung cancer and melanoma laid bare 4Health News:Lung cancer and melanoma laid bare 5Health News:Lung cancer and melanoma laid bare 6
... SAN DIEGO, Nov. 2 Forest,Laboratories, Inc. (NYSE: ... CYPB ),will host a webcast to discuss ... of Rheumatology annual conference. The webcast, which,will include ... 2007 at,10:00am EST. Representing Forest Laboratories will be ...
... could lead to new treatments, researchers say , , FRIDAY, Nov. ... molecular mechanism that makes blood pressure go up or down ... hypertension that affects at least 50 million Americans. , A ... Investigation is the latest in a series of studies ...
... Nov. 2 Barr,Pharmaceuticals, Inc. (NYSE: BRL ... has initiated a challenge of the patents listed ... LA,(methylphenidate hydrochloride) extended-release capsules, 10mg, 20mg, 30mg,and 40mg. ... (ANDA) containing a,paragraph IV certification for a generic ...
... Accredited Medical Supplies is inviting,seniors and caregivers in the ... 2007 from 11 a.m. -- 3 p.m. at a ... being held at 21142 Ventura Blvd in,Woodland Hills. ... aging,and lifestyle by also offering a variety of free ...
... Medical and Dental Clinic Services, HARRISBURG, Pa., ... Johnson today announced the award of more than ... expand access to,primary medical and dental care in ... to nonprofit organizations, local governments,and community-based health improvement ...
... how it leads to ,nervous breakdown, in the epidermis ... team of researchers has identified the biological mechanism by ... have shown what stress does, the basis of the ... of dermatology at the University of California, San Francisco, ...
Other Medicine News:Health News:Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran 2Health News:Study Describes Molecules That Control Blood Pressure 2Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 2Health News:Barr Confirms Patent Challenge of Ritalin(R) LA 3Health News:Accredited Medical Supplies Hosts Fall Health Festival 2Health News:PA Health Department Awards Community Primary Care Challenge Grants 2Health News:Stress Robs Skin of Antimicrobial Defenses 2
(Date:12/16/2009)... R.I., Dec. 16 CVS/pharmacy and MinuteClinic ... are now offering H1N1 vaccine in 20 states ... priority restrictions for receiving H1N1 vaccines continue, many ... be eligible to receive the shot while supplies ... been restocked and is available at MinuteClinic locations ...
(Date:12/16/2009)... Vivakor, Inc. (OTC Bulletin Board: VIVK) has ... Consulting out of Walnut Creek, California and ... of South Florida. Baker Consulting has ... business development, financing and assisting the company ... Baker Consulting is exploring potential acquisition targets ...
(Date:12/16/2009)... TechniScan, Inc. (OTC Bulletin Board: TSNI) ... engaged in the development and commercialization of an ... Joe Pepper, PhD, has been appointed to the ... Ken Hungerford commented, "Joe has extensive experience running ... OEC Medical and U-Systems, both of whom compete ...
Breaking Medicine Technology:CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 2CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 3CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C. 4Vivakor Signs Business Development Agreement With Baker Consulting 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 2In Preparation for Commercialization of SVARA(TM), TechniScan Appoints Joe Pepper, PhD to Board of Directors 3Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 1Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 2Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 3Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer 5034 4Girls violence on the rise 58132 1Girls violence on the rise 58132 2Discovery could improve hepatitis C treatment 58129 1Discovery could improve hepatitis C treatment 58129 2
... of Data for New Combination , , ... -- Combining the calcium channel blocker,amlodipine besylate ... mean reductions in,seated systolic and diastolic blood pressure ... the American Society,of Hypertension’s Twenty-Second Annual Scientific Meeting ...
... Survey Underscores Impact of Disease on Work Status ... today at Digestive Disease Week(R) 2007 (DDW), from,long-term ... 1,& 2) show that subjects with moderately to ... REMICADE(R),(infliximab) in the blinded phase of the trials ...
Other Medicine Technology:Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 2Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 3Amlodipine and Olmesartan Study Results Released;Late Breaker,Presented at American Society of Hypertension Twenty-Second Annual,Scientific Meeting (ASH 2007) 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 2Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 3Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 4Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 5Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 6Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 7Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 8Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up 9
Bivona® Uncuffed Neonatal and Pediatric Silicone Tracheostomy Tubes....
Fome-Cuf® tubes can breathe with the patient to provide a safe, effective, and low pressure seal throughout the ventilatory cycle....
... flange tracheostomy tubes are intended ... proper length fixed neck flange ... ,Adjustable neck flange Hyperflex™ ... for both horizontal and vertical ...
... KIMBERLY-CLARK BALLARD Neonatal ... MAC Catheter features a ... to deliver surfactants, lavage/irrigation ... port. Multiple French sizes ...
Medicine Products: